![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
New Zealand Health Groups Strive To Enhance Clinical Trials
Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials,...
Canadian And US Pharma Firms To Test Psychedelic Drugs In UK
To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug...
Immix Biopharma Announces Patient Dosing in Ongoing Phase 1b/2a IMX-110 Monotherapy Clinical Trial
Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases,...
By 2027, Market For Oligonucleotides Will Be Worth $16.7 Bn
The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology...
A Multi-Drug Trial On Cancer Precision Medicine Has Begun
A multi-drug, precision medicine trial involving Roche, the University of Manchester, and Cancer Research UK...
Digital Trials Evolving Due To Single, Connected Foundation
Clinical trials have expanded from 2,119 in 2000 to over 409,000 in 2022 (and counting)....
NICE Offers Historical Clinical Funding To Kidney Cancer UK
Through its approach to NHS England, the non-profit organisation Kidney Cancer UK was able to...
Edible Sensor Monitors HIV Patients Antiretroviral Doses
A new ingestible sensor system that was put to the test in an interventional clinical...
A New Initiative To Assess Clinical Trials Carbon Footprint
The Clinical Trials Environmental Impact Community of Interest (CoI), a cooperative effort that aims to...
Seven Pharma CEOs Team Together To Accomplish Emission Aims
Seven CEOs of pharmaceutical companies, including GSK, AstraZeneca, Merck, Roche, Novo Nordisk, Samsung Biologics, and Sanofi, have...